The US FDA is hosting a listening session to gather patient perspectives on oncogene-driven lung cancer. Representatives from several biomarker patient groups will speak; I will be speaking on behalf of The ROS1ders. Representatives from the FDA will share ways they are addressing the concerns raised by the patients.
When: Thursday, January 21, 2:30 pm to 4 pm ET.
Where: To receive a link to the event, register free at https://fdaoce.formstack.com/forms/nsclclisteningsession
If you’re unable to attend, you can watch the recording later.
Gray Connections 